Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/immunol.2.019
The role of MRI in detecting and characterizing brain metastases from breast cancer
Sana Mohammadi1, Sadegh Ghaderi2,*
- 1Department of Medical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
- 2Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Iran
Corresponding Author
Sadegh Ghaderi, s_ghaderi@razi.tums.ac.ir
Received Date: August 14, 2023
Accepted Date: August 28, 2023
Copyright: © 2023 Mohammadi S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
The role of MRI in detecting and characterizing brain metastases from breast cancer
Brain metastases are a feared complication of breast cancer, occurring in 15-25% of patients and being associated with poor prognosis and reduced quality of life. Magnetic resonance imaging (MRI) is an advanced technique that uses powerful magnetic fields and radio waves to produce detailed three-dimensional (3D) images of the brain's neuroanatomy and any potential pathology, especially in the management of brain metastases. The review article by Mohammadi et al. provides a timely and comprehensive overview of the utility of MRI for detecting and characterizing brain metastases from breast cancer.
The value of EGFR in individualized treatment for brain metastases in non-small cell lung cancer
The epidermal growth factor receptor (EGFR) is a member of the ErbB family. It is involved in biological processes such as cell proliferation, angiogenesis, inhibition of apoptosis, adhesion, metastasis, and is associated with the progression of lung cancer [1-3].
Cryoablation is a safe alternative to surgery for low-risk breast cancer
Cryoablation of breast cancer offers an alternative to surgery for women who are not ideal surgical candidates. It is a minimally invasive procedure that has already had success in fibroadenoma treatment with good tumor reduction and cosmesis. The findings of cryoablation as treatment for early-stage, low-risk breast cancer has been previously discussed in the recently published article ‘Cryoablation: A promising non-operative therapy for low-risk breast cancer’.
Cyclin A2 and Ki-67 proliferation markers could be used to identify tumors with poor prognosis in African American women with breast cancer
Eight protein biomarkers (ER, PR, HER2, Cyclin A2, Cytokeratin 5, Vimentin, Bcl2, and Ki-67) were evaluated using tissue microarrays (TMAs) and immunohistochemistry (IHC). The IHC results from TMAs were analyzed by both supervised and unsupervised clustering methods. The predictive clusters for the supervised and unsupervised methods were compared for agreement with the empirical classification. Kappa values were used to determine the overall percent correct clusters and agreement between specific clusters.
Progress and perspectives of organoid cultures of primary human breast cancer
The prospect of precision or personalized medicine has revived the entire field of predictive drug testing originally pursued in clonogenic assays and soft agar colony forming assays some four decades ago. In particular, the human breast and its derived tumors, while relatively trivial in composition, have proven enormously difficult to establish and interpret ex vivo.